€54.04
0.00% today
Helsinki, Feb 28, 04:42 pm CET
ISIN
FI0009014377
Symbol
ORNBV
Sector
Industry

Orion Stock price

€54.04
+3.44 6.80% 1M
+7.38 15.82% 6M
+11.26 26.32% YTD
+17.02 45.98% 1Y
+12.05 28.70% 3Y
+17.60 48.30% 5Y
+25.06 86.50% 10Y
Helsinki, Closing price Thu, Feb 27 2025
-0.56 1.03%
ISIN
FI0009014377
Symbol
ORNBV
Sector
Industry

Key metrics

Market capitalization €7.59b
Enterprise Value €7.71b
P/E (TTM) P/E ratio 23.03
EV/FCF (TTM) EV/FCF 33.37
EV/Sales (TTM) EV/Sales 5.00
P/S ratio (TTM) P/S ratio 4.92
P/B ratio (TTM) P/B ratio 7.55
Dividend yield 3.03%
Last dividend (FY25) €1.64
Revenue growth (TTM) Revenue growth 29.45%
Revenue (TTM) Revenue €1.54b
EBIT (operating result TTM) EBIT €407.10m
Free Cash Flow (TTM) Free Cash Flow €231.20m
Cash position €205.60m
EPS (TTM) EPS €2.35
P/E forward 21.38
P/S forward 4.58
EV/Sales forward 4.66
Show more

Is Orion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Orion Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Orion forecast:

3x Buy
50%
1x Hold
17%
2x Sell
33%

Analyst Opinions

6 Analysts have issued a Orion forecast:

Buy
50%
Hold
17%
Sell
33%

Financial data from Orion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,542 1,542
29% 29%
100%
- Direct Costs 596 596
12% 12%
39%
946 946
43% 43%
61%
- Selling and Administrative Expenses 267 267
8% 8%
17%
- Research and Development Expense 180 180
42% 42%
12%
500 500
76% 76%
32%
- Depreciation and Amortization 93 93
80% 80%
6%
EBIT (Operating Income) EBIT 407 407
75% 75%
26%
Net Profit 330 330
52% 52%
21%

In millions EUR.

Don't miss a Thing! We will send you all news about Orion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.

Head office Finland
CEO Aino Hurme
Employees 3,880
Founded 1917
Website www.orion.fi

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today